However, scutellarin treatment down-regulated the ratio of p-65/p65 and induced higher expression of IκBα in a dose-dependent way (Fig. 2A), indicating that scutellarin suppressed BLM-induced activation of NF-κB signaling pathway. The gene discussed is NFKBIA; the disease is Bloom syndrome.